PROGEN (PROGEN) News
Follow PROGEN (PROGEN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Prostatype Genomics AB OMXSTO:PROGEN
NEWS | Sep 23, 2026, 02:11 PM UTC
L
Prostatype Genomics AB (PROGEN) Says Medicare Review Ongoing; Timing Uncertain
Prostatype Genomics AB said its Medicare reimbursement process for Prostatype is ongoing, with dialogue now focused on a limited number of remaining issues. There is no set deadline, and the company will not speculate on
NEWS | Sep 23, 2026, 02:10 PM UTC
L
Prostatype Genomics AB TO6 warrants last trading day is tomorrow
TradingView News reports that the last day of trading in Prostatype Genomics AB’s warrants of series TO6 is tomorrow.
MACRO | Sep 10, 2026, 10:00 AM UTC
L
Exercise period begins today for TO6 warrants
The exercise period for warrants of series TO6 starts today.
EQUITY | Sep 01, 2026, 06:45 AM UTC
L
PROGEN: Net sales grew, losses narrowed, and a major rights issue secured funding for U.S. expansion
PROGEN: Net sales grew, losses narrowed, and a major rights issue secured funding for U.S. expansion
EQUITY | Aug 31, 2026, 07:32 AM UTC
L
Prostatype Genomics reports H1 2026 net sales of SEK 457,000
Prostatype Genomics AB reports H1 2026 net sales of SEK 457,000.
EQUITY | Aug 31, 2026, 07:31 AM UTC
L
Prostatype Genomics publishes interim report for H1 2026
Prostatype Genomics has published its interim report for the first half of 2026.
EQUITY | Aug 31, 2026, 07:30 AM UTC